{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T07:22:30Z","timestamp":1764919350982,"version":"3.46.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Science and Technology Innovation Leading Talent Program of Liaoning Province","award":["XLYC1902036"],"award-info":[{"award-number":["XLYC1902036"]}]},{"name":"the \"1+X\" Program Summit Construction Project of Second Hospital of Dalian Medical University"},{"name":"the Research projects","award":["HXLX20240065"],"award-info":[{"award-number":["HXLX20240065"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01726-8","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T11:11:35Z","timestamp":1751454695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antitumor effects of human antithymocyte globulin on peripheral T cell lymphoma via complement-dependent and -independent cytotoxicity in xenograft mouse models"],"prefix":"10.1007","volume":"25","author":[{"given":"Bei-Bei","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Jie","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Lan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Song","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"1726_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2021.100126","volume":"10","author":"SE Yoon","year":"2021","unstructured":"Yoon SE, Song Y, Kim SJ, Yoon DH, Chen TY, Koh Y, Kang KW, Lee HS, Tay KKW, Lim ST, Poon M, Irawan C, Zhao W, Do YR, Lee MH, Ng SC, Lee WS, Guo Y, Zhang H, Kang HJ, Yun HJ, Kim HJ, Lung DTC, Kwak JY, Han JJ, Mun YC, Oh SY, Shim H, Kwon JH, Sohn BS, Park SK, Jo JC, Ko YH, Jun Z, Kim WS. Comprehensive analysis of peripheral T-cell and natural killer\/T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia. Lancet Reg Health West Pac. 2021;10: 100126. https:\/\/doi.org\/10.1016\/j.lanwpc.2021.100126.","journal-title":"Lancet Reg Health West Pac"},{"issue":"7","key":"1726_CR2","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, Bhagat G, Borges AM, Boyer D, Calaminici M, Chadburn A, Chan JKC, Cheuk W, Chng WJ, Choi JK, Chuang SS, Coupland SE, Czader M, Dave SS, de Jong D, Du MQ, Elenitoba-Johnson KS, Ferry J, Geyer J, Gratzinger D, Guitart J, Gujral S, Harris M, Harrison CJ, Hartmann S, Hochhaus A, Jansen PM, Karube K, Kempf W, Khoury J, Kimura H, Klapper W, Kovach AE, Kumar S, Lazar AJ, Lazzi S, Leoncini L, Leung N, Leventaki V, Li XQ, Lim MS, Liu WP, Louissaint A Jr, Marcogliese A, Medeiros LJ, Michal M, Miranda RN, Mitteldorf C, Montes-Moreno S, Morice W, Nardi V, Naresh KN, Natkunam Y, Ng SB, Oschlies I, Ott G, Parrens M, Pulitzer M, Rajkumar SV, Rawstron AC, Rech K, Rosenwald A, Said J, Sarkozy C, Sayed S, Saygin C, Schuh A, Sewell W, Siebert R, Sohani AR, Tooze R, Traverse-Glehen A, Vega F, Vergier B, Wechalekar AD, Wood B, Xerri L, Xiao W. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36(7):1720\u201348. https:\/\/doi.org\/10.1038\/s41375-022-01620-2.","journal-title":"Leukemia"},{"key":"1726_CR3","doi-asserted-by":"publisher","first-page":"v108","DOI":"10.1093\/annonc\/mdv201","volume":"26","author":"F d'Amore","year":"2015","unstructured":"d\u2019Amore F, Gaulard P, Trumper L, Corradini P, Kim WS, Specht L, Bjerregaard Pedersen M, Ladetto M, Committee EG. Peripheral T-cell lymphomas: ESMO Clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26:v108-115. https:\/\/doi.org\/10.1093\/annonc\/mdv201.","journal-title":"Ann Oncol"},{"issue":"5","key":"1726_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/CCO.0000000000000469","volume":"30","author":"C Gisselbrecht","year":"2018","unstructured":"Gisselbrecht C, Sibon D. New perspectives in the therapeutic approach of peripheral T-cell lymphoma. Curr Opin Oncol. 2018;30(5):285\u201391. https:\/\/doi.org\/10.1097\/CCO.0000000000000469.","journal-title":"Curr Opin Oncol"},{"issue":"9","key":"1726_CR5","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1200\/JCO.2010.29.9024","volume":"29","author":"OA O'Connor","year":"2011","unstructured":"O\u2019Connor OA, Pro B, Pinter-Brown L, Bartlett N, Popplewell L, Coiffier B, Lechowicz MJ, Savage KJ, Shustov AR, Gisselbrecht C, Jacobsen E, Zinzani PL, Furman R, Goy A, Haioun C, Crump M, Zain JM, Hsi E, Boyd A, Horwitz S. Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study. J Clin Oncol. 2011;29(9):1182\u20139. https:\/\/doi.org\/10.1200\/JCO.2010.29.9024.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1726_CR6","doi-asserted-by":"publisher","first-page":"469","DOI":"10.18926\/AMO\/57379","volume":"73","author":"S Yamasaki","year":"2019","unstructured":"Yamasaki S, Kada A, Nagai H, Yoshida I, Choi I, Saito AM, Iwasaki H. Phase II trial using romidepsin after gemcitabine, dexamethasone, and cisplatin therapy in elderly transplant-ineligible patients with relapsed\/refractory peripheral T-Cell lymphoma: study protocol. Acta Med Okayama. 2019;73(5):469\u201374. https:\/\/doi.org\/10.18926\/AMO\/57379.","journal-title":"Acta Med Okayama"},{"issue":"4","key":"1726_CR7","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.hoc.2019.04.002","volume":"33","author":"SY Ng","year":"2019","unstructured":"Ng SY, Jacobsen ED. Peripheral T-Cell lymphoma: moving toward targeted therapies. Hematol Oncol Clin North Am. 2019;33(4):657\u201368. https:\/\/doi.org\/10.1016\/j.hoc.2019.04.002.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"12","key":"1726_CR8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/bmt.2008.332","volume":"42","author":"A Gutierrez","year":"2008","unstructured":"Gutierrez A, Caballero MD, Perez-Manga G, Rodriguez J. Hematopoietic SCT for peripheral T-cell lymphoma. Bone Marrow Transplant. 2008;42(12):773\u201381. https:\/\/doi.org\/10.1038\/bmt.2008.332.","journal-title":"Bone Marrow Transplant"},{"issue":"16","key":"1726_CR9","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1200\/JCO.2012.44.7524","volume":"31","author":"V Mak","year":"2013","unstructured":"Mak V, Hamm J, Chhanabhai M, Shenkier T, Klasa R, Sehn LH, Villa D, Gascoyne RD, Connors JM, Savage KJ. Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors. J Clin Oncol. 2013;31(16):1970\u20136. https:\/\/doi.org\/10.1200\/JCO.2012.44.7524.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1726_CR10","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/bjh.14477","volume":"176","author":"D Chihara","year":"2017","unstructured":"Chihara D, Fanale MA, Miranda RN, Noorani M, Westin JR, Nastoupil LJ, Hagemeister FB, Fayad LE, Romaguera JE, Samaniego F, Turturro F, Lee HJ, Neelapu SS, Rodriguez MA, Wang M, Fowler NH, Davis RE, Medeiros LJ, Hosing C, Nieto YL, Oki Y. The survival outcome of patients with relapsed\/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma. Br J Haematol. 2017;176(5):750\u20138. https:\/\/doi.org\/10.1111\/bjh.14477.","journal-title":"Br J Haematol"},{"issue":"3","key":"1726_CR11","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1182\/bloodadvances.2021005899","volume":"6","author":"M Hamadani","year":"2022","unstructured":"Hamadani M, Ngoya M, Sureda A, Bashir Q, Litovich CA, Finel H, Chen Y, Boumendil A, Zain J, Castagna L, Cashen AF, Blaise D, Shadman M, Pastano R, Khimani F, Arat M, Dietrich S, Schmitz N, Glass B, Kharfan-Dabaja MA, Corradini P, Sauter CS, Montoto S, Kwon M, Herrera AF, Dreger P. Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics. Blood Adv. 2022;6(3):920\u201330. https:\/\/doi.org\/10.1182\/bloodadvances.2021005899.","journal-title":"Blood Adv"},{"issue":"5","key":"1726_CR12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.9807","volume":"4","author":"J Du","year":"2021","unstructured":"Du J, Yu D, Han X, Zhu L, Huang Z. Comparison of allogeneic stem cell transplant and autologous stem cell transplant in refractory or relapsed peripheral T-Cell lymphoma: a systematic review and meta-analysis. JAMA Netw Open. 2021;4(5): e219807. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.9807.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"1726_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.54","volume":"5","author":"J Yang","year":"2015","unstructured":"Yang J, Cai Y, Jiang JL, Wan LP, Yan SK, Wang C. Anti-thymocyte globulin could improve the outcome of allogeneic hematopoietic stem cell transplantation in patients with highly aggressive T-cell tumors. Blood Cancer J. 2015;5(7): e332. https:\/\/doi.org\/10.1038\/bcj.2015.54.","journal-title":"Blood Cancer J"},{"issue":"4","key":"1726_CR14","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1080\/10428194.2021.1999438","volume":"63","author":"V Singh","year":"2022","unstructured":"Singh V, Kim S, Deol A, Uberti JP, Modi D. Allogeneic hematopoietic stem cell transplantation in T-cell lymphoma: a Meta-Analysis. Leuk Lymphoma. 2022;63(4):855\u201364. https:\/\/doi.org\/10.1080\/10428194.2021.1999438.","journal-title":"Leuk Lymphoma"},{"key":"1726_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.12.009","author":"CH Sterling","year":"2022","unstructured":"Sterling CH, Hughes MS, Tsai HL, Yarkony K, Fuchs EJ, Swinnen LJ, Paul S, Bolanos-Meade J, Luznik L, Imus PH, Ali SA, Jain T, Ambinder A, DeZern A, Huff CA, Gocke CB, Varadhan R, Wagner-Johnston N, Jones RJ, Ambinder RF. Allogeneic blood or marrow transplantation with post-transplantation cyclophosphamide for peripheral T Cell lymphoma: the importance of graft source. Transpl Cell Ther. 2022. https:\/\/doi.org\/10.1016\/j.jtct.2022.12.009.","journal-title":"Transpl Cell Ther"},{"key":"1726_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cells12030382","author":"D Copic","year":"2023","unstructured":"Copic D, Direder M, Klas K, Bormann D, Laggner M, Ankersmit HJ, Mildner M. Antithymocyte globulin inhibits CD8(+) T Cell effector functions via the paracrine induction of PDL-1 on monocytes. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12030382.","journal-title":"Cells"},{"issue":"1","key":"1726_CR17","first-page":"152","volume":"15","author":"X-H Zhang","year":"2007","unstructured":"Zhang X-H, Huang X-J, Liu K-Y, Xu L-P, Liu D-H. D-P Lu (2007) Pharmacokinetics of antithymocyte globulin in recipients under-going HLA partially matched hematopoietic stem cell transplantation. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007;15(1):152\u20135.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"5","key":"1726_CR18","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/0002-9343(85)90066-x","volume":"79","author":"RF Hunter","year":"1985","unstructured":"Hunter RF, Roth PA, Huang AT. Cutaneous T cell lymphoma. Lymphocyte phenotype analysis after anti-thymocyte globulin therapy. Am J Med. 1985;79(5):653\u20138. https:\/\/doi.org\/10.1016\/0002-9343(85)90066-x.","journal-title":"Am J Med"},{"issue":"7","key":"1726_CR19","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1182\/blood-2005-06-2269","volume":"107","author":"MS Zand","year":"2006","unstructured":"Zand MS, Vo T, Pellegrin T, Felgar R, Liesveld JL, Ifthikharuddin JJ, Abboud CN, Sanz I, Huggins J. Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin. Blood. 2006;107(7):2895\u2013903. https:\/\/doi.org\/10.1182\/blood-2005-06-2269.","journal-title":"Blood"},{"issue":"7","key":"1726_CR20","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.leukres.2002.11.001","volume":"29","author":"A Yoshimi","year":"2005","unstructured":"Yoshimi A, Ito M, Kojima S. Leukemic cell death induced by antithymocyte globulin. Leuk Res. 2005;29(7):821\u20137. https:\/\/doi.org\/10.1016\/j.leukres.2002.11.001.","journal-title":"Leuk Res"},{"issue":"10","key":"1726_CR21","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.exphem.2014.07.260","volume":"42","author":"S Westphal","year":"2014","unstructured":"Westphal S, Brinkmann H, Kalupa M, Wilke A, Seitz-Merwald I, Penack O. Anti-tumor effects of anti-T-cell globulin. Exp Hematol. 2014;42(10):875\u201382. https:\/\/doi.org\/10.1016\/j.exphem.2014.07.260.","journal-title":"Exp Hematol"},{"issue":"10","key":"1726_CR22","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1038\/sj.leu.2404359","volume":"20","author":"MM Timm","year":"2006","unstructured":"Timm MM, Kimlinger TK, Haug JL, Kline MP, Greipp PR, Rajkumar SV, Kumar SK. Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myeloma. Leukemia. 2006;20(10):1863\u20139. https:\/\/doi.org\/10.1038\/sj.leu.2404359.","journal-title":"Leukemia"},{"issue":"1","key":"1726_CR23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13045-020-01006-w","volume":"13","author":"K Izykowska","year":"2020","unstructured":"Izykowska K, Rassek K, Korsak D, Przybylski GK. Novel targeted therapies of T cell lymphomas. J Hematol Oncol. 2020;13(1):176. https:\/\/doi.org\/10.1186\/s13045-020-01006-w.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"1726_CR24","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s11684-020-0807-4","volume":"15","author":"H Liu","year":"2021","unstructured":"Liu H, Zheng X, Zhang C, Xie J, Gao B, Shao J, Yang Y, Wang H, Yan J. Outcomes of haploidentical bone marrow transplantation in patients with severe aplastic anemia-II that progressed from non-severe acquired aplastic anemia. Front Med. 2021;15(5):718\u201327. https:\/\/doi.org\/10.1007\/s11684-020-0807-4.","journal-title":"Front Med"},{"issue":"1","key":"1726_CR25","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1038\/s41598-024-52917-4","volume":"14","author":"C Zhang","year":"2024","unstructured":"Zhang C, Hou Y, Yang Y, Zhang J, Zheng X, Yan J. Second haploidentical bone marrow transplantation with antithymocyte antibody-containing conditioning regimen for graft failure in eight patients with severe aplastic anemia. Sci Rep. 2024;14(1):2293. https:\/\/doi.org\/10.1038\/s41598-024-52917-4.","journal-title":"Sci Rep"},{"issue":"7","key":"1726_CR26","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/sj.leu.2404683","volume":"21","author":"M Mohty","year":"2007","unstructured":"Mohty M. Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia. 2007;21(7):1387\u201394. https:\/\/doi.org\/10.1038\/sj.leu.2404683.","journal-title":"Leukemia"},{"key":"1726_CR27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12935-019-1027-3","volume":"19","author":"R Zhang","year":"2019","unstructured":"Zhang R, Liu Q, Li T, Liao Q, Zhao Y. Role of the complement system in the tumor microenvironment. Cancer Cell Int. 2019;19:300. https:\/\/doi.org\/10.1186\/s12935-019-1027-3.","journal-title":"Cancer Cell Int"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01726-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01726-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01726-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:52:34Z","timestamp":1764917554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01726-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1726"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01726-8","relation":{},"ISSN":["1591-9528"],"issn-type":[{"type":"electronic","value":"1591-9528"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal experiment of the study was approved by the Wuhan Servicebio Technology Co., Ltd. Institutional Animal Care and Use Committee (IACUC).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"231"}}